Table of contents

November 2005 - Volume 64 - suppl 4

Advances in targeted therapies VII


Consensus statement

Novel aspects of cellular immunology

Issues in clinical trial design

Adverse events with biologics

Joint damage

Update on biologicals

Psoriasis, psoriatic arthritis, ankylosing spondylitis, and other aspects

TNF effects and therapeutic response

Molecular basis of the immune response

New targets I

New targets II

New targets III

Issue Information